AIM ImmunoTech Ownership & Insider Activity

AIM ImmunoTech (AIM) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 16.5% of shares outstanding. Institutional investors hold 0.1%. Over the past 90 days, insiders made 6 purchases worth $24K.

Shares Outstanding

39.179M

Shares Float

39.037M

Insider Shares Owned

6.469M

Insider % Owned

16.5%

Institutional Shares Held

46.003K

Institutional % Held

0.1%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$24K total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$24K

AIM ImmunoTech Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 23, 2026	Thomas K Equels	CEO & PRESIDENT	BUY	31.675K	$0.16	$5K
Oct 22, 2026	Thomas K Equels	CEO & PRESIDENT	BUY	31.250K	$0.16	$5K
Sep 17, 2026	Thomas K Equels	CEO & PRESIDENT	BUY	24.000K	$0.21	$5K
Sep 16, 2026	Thomas K Equels	CEO & PRESIDENT	BUY	11.000K	$0.21	$2K
Sep 15, 2026	Thomas K Equels	CEO & PRESIDENT	BUY	22.000K	$0.22	$5K
Sep 14, 2026	Thomas K Equels	CEO & PRESIDENT	BUY	5.900K	$0.22	$1K